Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Brand name: Incruse Ellipta TM
Listen to the Pronunciation:
Active ingredients: umeclidinium
What it is used for
Incruse Ellipta is indicated as a long term once daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD)
How to take it
The way to take this medicine is: Inhalation.
- Store below 30 degrees Celsius
- See Product information for shelf life
- Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
A plastic inhaler with a light grey body and a light green mouthpiece cover containing one strip of blister containing a white powder.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient umeclidinium
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
